Seremind line tackles anxiety
This article was originally published in OTC Bulletin
Australian consumers suffering with mild anxiety, nervous tension and poor sleep quality have a new OTC option with the launch of Seremind by Italy’s Menarini.
You may also be interested in...
After most of the big pharmaceutical companies reported their full-year 2019 financial results, the second month of earnings season brings the long tail of smaller biotech companies and the generic pharmaceutical companies. There is more than one uncomfortable parallel from the former in the reports of the latter.
The HMA-EMA Big Data Task Force has offered recommendations to use data for the benefit of public health.